ON THE SIGNIFICANCE OF SERUM DILUTION AND CORTISOL ANTAGONISM IN THE RAT FAT PAD BIOASSAY OF INSULIN

1968 ◽  
Vol 58 (1) ◽  
pp. 11-26 ◽  
Author(s):  
Ingmar Lundquist

ABSTRACT The dilution effect of normal human serum was readily detectable at small dilutions (1:3, 1:4) and was present to about the same extent both in males and females. It was found to be significantly greater in elderly as compared to younger subjects. Adrenalectomized rats had a significantly lower SILA level in undiluted serum than normal rats. Alloxan diabetic rats had a SILA level in undiluted serum, of about one third of the SILA level in normal rats. In contrast to normal human serum, any dilution effect of normal rat serum was detectable only at very high dilutions (1:27). The same pattern was found when serum from adrenalectomized and alloxan diabetic rats were assayed. The dilution effect in human serum is considered to be due mainly to a species difference. The smallest concentration of cortisol which produced a significant suppression of glucose utilization (as measured on the 14CO2 production from Glucose-1-14C) by rat epididymal fat pads in vitro, in the absence of insulin, was of the order of 0.0025 μg per ml (7 × 10−9 m). A linear log dose-response relationship was found between 0.0025 and 0.25 μg per ml and thus was well within the physiological range. Physiological concentrations of cortisol significantly suppressed the effect of submaximal concentrations of insulin on the 14CO2 production from Glucose-1-14C by the epididymal adipose tissue. A maximal insulin concentration abolished this cortisol effect. However, an extremely high concentration of cortisol (25 μg per ml) still inhibited the effect of 10 U insulin per ml to a slight extent. Addition of puromycin (5 × 10−5 m) abolished the suppressive effect of a physiological concentration of cortisol on insulin stimulated 14CO2 formation from Glucose-1-14C. The mechanism of the observed antagonism between insulin and cortisol at physiological concentrations is assumed to be of the competitive type mediated not by cortisol itself, but by a protein, the formation of which is induced by the action of cortisol.

1982 ◽  
Vol 28 (1) ◽  
pp. 119-121 ◽  
Author(s):  
E Piall ◽  
G W Aherne ◽  
V Marks

Abstract We evaluated a commercially available (Diagnostic Biochemistry Inc.) doxorubicin 125I radioimmunoassay kit. This kit gave a high apparent doxorubicin concentration (greater than 12 micrograms/L), which was not linearly related to dilution, for two pools of normal human serum and plasma and also for samples collected from patients before they received the drug. In contrast, a doxorubicin 3H radioimmunoassay developed by us gave a low blank (2 micrograms/L), which was linearly related to dilution, for the same pools and patients' samples. Doxorubicin concentrations in the plasma of patients receiving the drug were compared by the two methods; the kit gave results five- to 10-fold those obtained with our assay. High nonspecific interference by serum and plasma as measured by the 125I radioimmunoassay must therefore be borne in mind by users of the kit, and we suggest that results should be corrected for these nonspecific effects.


Biochemistry ◽  
1963 ◽  
Vol 2 (2) ◽  
pp. 286-289 ◽  
Author(s):  
Walter N. Shaw ◽  
Eldon W. Shuey

2003 ◽  
Vol 10 (2) ◽  
pp. 216-220
Author(s):  
Marlene Pereira de Carvalho Florido ◽  
Patrícia Ferreira de Paula ◽  
Lourdes Isaac

ABSTRACT Due to the increasing numbers of reported clinical cases of complement deficiency in medical centers, clinicians are now more aware of the role of the complement system in the protection against infections caused by microorganisms. Therefore, clinical laboratories are now prepared to perform a number of diagnostic tests of the complement system other than the standard 50% hemolytic component assay. Deficiencies of alternative complement pathway proteins are related to severe and recurrent infections; and the application of easy, reliable, and low-cost methods for their detection and distinction are always welcome, notably in developing countries. When activation of the alternative complement pathway is evaluated in hemolytic agarose plates, some but not all human sera cross-react to form a late linear lysis. Since the formation of this linear lysis is dependent on C3 and factor B, it is possible to use late linear lysis to routinely screen for the presence of deficiencies of alternative human complement pathway proteins such as factor B. Furthermore, since linear lysis is observed between normal human serum and primary C3-deficient serum but not between normal human serum and secondary C3-deficient serum caused by the lack of factor H or factor I, this assay may also be used to discriminate between primary and secondary C3 deficiencies.


1987 ◽  
Vol 15 (3) ◽  
pp. 255-259 ◽  
Author(s):  
Jorge R. Geffner ◽  
Mirta Giordano ◽  
Graciela P. Serebrinsky ◽  
Marina S. Palermo ◽  
Martin A. Isturiz

Sign in / Sign up

Export Citation Format

Share Document